New biomarker assay detects neuroblastoma with greater sensitivity
(Children's Hospital Los Angeles) Investigators at The Saban Research Institute of Children's Hospital Los Angeles have developed and tested a new biomarker assay for quantifying disease and detecting the presence of neuroblastoma even when standard evaluations yield negative results for the disease. Researchers provide the first systematic comparison of standard imaging evaluations versus the new assay that screens for five different neuroblastoma-associated genes and determine that the new assay improves disease assessment and provides prediction of disease progression. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 22, 2017 Category: International Medicine & Public Health Source Type: news

New research points to potential for more targeted treatments of neuroblastoma tumors
(University of Chicago Medical Center) Genetic variations appear to pre-dispose children to developing certain severe forms of neuroblastoma, according to new research by the University of Chicago Medicine. The findings lay the groundwork for developing more targeted treatments for particularly deadly variations of the cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 19, 2017 Category: Cancer & Oncology Source Type: news

There's a good reason this last-day-of-school photo is melting hearts
When 7-year-old Sophi Eber began kindergarten, she was in the fight of her young life with stage IV neuroblastoma. She's now cancer-free. (Source: CNN.com - Health)
Source: CNN.com - Health - June 9, 2017 Category: Consumer Health News Source Type: news

FDA grants breakthrough therapy status to MSK ’s Burtomab neuroblastoma therapy
Memorial Sloan Kettering Cancer Center (MSK)-developed Burtomab has received breakthrough therapy designation from the US Food and Drug Administration (FDA) for the treatment of pediatric patients with relapsed or refractory neuroblastoma with centra … (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - June 7, 2017 Category: Pharmaceuticals Source Type: news

First grader shares photos after she beat stage 4 cancer  
Sophi Eber, seven, shared an inspiring picture of her first and last day of first grade. The Missouri little girl had beaten her stage 4 neuroblastoma and fully recovered in the time span. (Source: the Mail online | Health)
Source: the Mail online | Health - June 7, 2017 Category: Consumer Health News Source Type: news

Girl Inspires With Viral Pics Of Her First And Last Days Of First Grade
For many kids, taking photos on the first and last days of school allows them to see how much they’ve grown. For 7-year-old Sophi Eber, the photos let her also see how far she’s come in her battle with cancer. On Sophi’s last day of first grade, her teacher took a photo of the 7-year-old holding up a photo that showed her on her first day of the school year. In the first photo, Sophi has no hair and no eyebrows and has a tube in her nose. In the newer photo, she has a full head of hair and is tube-free. That’s because this school year, Sophi has been recovering after being declared cancer-...
Source: Healthy Living - The Huffington Post - June 5, 2017 Category: Consumer Health News Source Type: news

Twist of fate: Anna reconnects with the oncologist who saved her life
Credit: Mark Dela Cruz Anna Protsiou was five in 2002 when she was diagnosed with neuroblastoma. She remembers pain and the fruit-scented anesthesia masks that led her to stop eating cherries. She remembers hospital arts and crafts projects. What she barely remember is the pediatric oncologist who saved her life. She was a young girl then who didn’t speak English, moving with her family from their native Greece to be treated for a year at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center. Now, after moving with her family to Canada in 2014, she’s a 20-year-old dance student at the Eg. School of Contempo...
Source: Thrive, Children's Hospital Boston - June 2, 2017 Category: Pediatrics Authors: Irene Sege Tags: Diseases & Conditions Our Patients’ Stories Research and Innovation Dana-Farber/Boston Children's Cancer and Blood Disorders Center Lisa Diller MD neuroblastoma Source Type: news

New molecular target to improve neuroblastoma treatment
A new study has served to identify some genetic mutations that will help to improve the treatment of neuroblastoma. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - May 19, 2017 Category: Science Source Type: news

Dinutuximab beta for the Treatment of Neuroblastoma
Dinutuximab beta is an anti-GD2 monoclonal antibody indicated for the treatment of neuroblastoma in patients aged one year and above. (Source: Drug Development Technology)
Source: Drug Development Technology - May 18, 2017 Category: Pharmaceuticals Source Type: news

Cancer drug to treat deadly neuroblastoma can be prescribed on NHS - new hope for children
A CANCER drug which could help treat a rare form of cancer called neuroblastoma, has been given the green-light for use by health bosses in Europe. Bradley Lowery, who has recently hit the headlines for his friendship with footballer Jermaine Defoe, is fighting the disease. (Source: Daily Express - Health)
Source: Daily Express - Health - May 10, 2017 Category: Consumer Health News Source Type: news

EUSA Pharma receives EC approval for dinutuximab beta antibody to treat neuroblastoma
EUSA Pharma has secured European Commission (EC) approval for the antibody ch14.18/CHO, (dinutuximab beta) to be used in treating high-risk neuroblastoma in patients older than a year. (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - May 9, 2017 Category: Pharmaceuticals Source Type: news

Marker May Predict Immunotherapy Benefit in High-Risk Neuroblastoma
This video examines how a specific combination of KIR/KIR-ligand genotypes in high-risk neuroblastoma patients may be predictive of outcomes when adding dinutuximab to isotretinoin. (Source: CancerNetwork)
Source: CancerNetwork - April 8, 2017 Category: Cancer & Oncology Authors: Amy K. Erbe, PhD Tags: Conferences/AACR 2017 Brain Tumors Source Type: news

EMA issues positive opinion for EUSA Pharma's Dinutuximab beta to treat neuroblastoma
The European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion in favour of marketing authorisation for EUSA Pharma's antibody ch14.18/CHO, Dinutuximab beta, to treat high-risk neuroblastoma … (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - March 28, 2017 Category: Pharmaceuticals Source Type: news

WATCH: Firefighters shave heads to support colleague's son with cancer
Caleb Lambert, 3, was diagnosed with stage 3 neuroblastoma on Feb. 11. (Source: ABC News: Health)
Source: ABC News: Health - March 27, 2017 Category: Consumer Health News Tags: Lifestyle Source Type: news

Dinutuximab beta receives positive recommendation for the treatment of high-risk neuroblastoma in Europe
HEMEL HEMPSTEAD, England, March 27, 2017 -- (Healthcare Sales & Marketing Network) --EUSA Pharma today announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion in favour of marketin... Biopharmaceuticals, Oncology, Regulatory EUSA Pharma, Dinutuximab beta, neuroblastoma (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 27, 2017 Category: Pharmaceuticals Source Type: news